Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation.
Cavaillé-Coll
M W
MW
Elashoff
M R
MR
D044383:Black People; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000209:etiology; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects; D006630:Hispanic or Latino; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D044465:White People
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus